Status:
RECRUITING
Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis
Lead Sponsor:
Lyv Healthcare
Conditions:
Endometriosis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The main objective of this clinical study is to evaluate the clinical impact of using an innovative digital therapeutic device on the quality of life of patients with endometriosis. The working hypot...
Detailed Description
Endometriosis is a chronic, systemic, and inflammatory disease. Long considered a gynecological condition, endometriosis is now recognized as a systemic disease associated with symptoms and comorbidit...
Eligibility Criteria
Inclusion
- Women ≥18 years old
- with confirmed endometriosis diagnosis
- symptomatic patients (NRS ≥ 4 on one or more symptoms)
- French-speaking
- Owning a smartphone with internet/data,
- covered by French social security
Exclusion
- Planned surgery during the study or surgery in the past 8 weeks
- Fertility hormone treatment during study
- Previous use of full Lyv Endo app or pilot program
- Pregnant or breastfeeding
- Under legal protection (guardianship, etc.)
- Cognitive or psychiatric conditions compromising consent
- Judged non-autonomous by investigator
- Participation in another interventional study
Key Trial Info
Start Date :
July 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT07175857
Start Date
July 21 2025
End Date
August 31 2026
Last Update
September 16 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Tivoli Ducos
Bordeaux, France, 33000
2
Centre Hospitalier de Versailles
Le Chesnay, France, 78157
3
Centre Hospitalier Le Mans
Le Mans, France, 72000
4
Hôpital Le Blois
Lille, France, 59000